Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 13.968.0318.19-3.744.71

What is the latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 13.96 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.96
Mar20238.03
Mar202218.19
Mar2021-3.74
Mar20204.71

How is Core EBITDA Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 13.96
73.85
Mar2023 8.03
-55.85
Mar2022 18.19
Positive
Mar2021 -3.74
Negative
Mar2020 4.71 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹37,342.5 Cr 11.1% 0.7% -6.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

11.1%

0.7%

-6.7%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses